Verve Therapeutics Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Rental Revenue	711.27	694.48	666.84	625.86	613.33	657.98	Upgrade
Other Revenue	154.11	149.9	135.55	118.1	129.65	132.7	Upgrade
Total Revenue	865.37	844.38	802.39	743.95	742.98	790.68	Upgrade
Revenue Growth (YoY	6.32%	5.23%	7.85%	0.13%	-6.03%	-3.82%	Upgrade
Property Expenses	198.54	201.21	209.59	177.26	113.8	188.54	Upgrade
Selling, General & Administrative	76.44	76.32	77.86	79.72	80.48	91.8	Upgrade
Depreciation & Amortization	11.53	11.7	11.28	9.88	11.11	9.66	Upgrade
Other Operating Expenses	-67.74	4.49	2.89	-5.45	67.21	7.1	Upgrade
Total Operating Expenses	218.76	293.73	301.62	261.4	272.6	297.09	Upgrade
Operating Income	646.61	550.65	500.77	482.56	470.38	493.59	Upgrade
Interest Expense	-95.17	-90.36	-88.16	-83.08	-88.93	-94.68	Upgrade
Interest & Investment Income	-	-	-	-	6.7	3.55	Upgrade
Currency Exchange Gain (Loss)	-0.02	-0.03	-0.04	-0	0.4	0.23	Upgrade
Other Non-Operating Income	-49.35	-24.31	-68.02	53.01	11.5	-23.77	Upgrade
EBT Excluding Unusual Items	502.07	435.96	344.54	452.49	400.05	378.91	Upgrade
Impairment of Goodwill	-	-	-17.46	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	1.55	0.67	66.97	5.38	24.4	-4.32	Upgrade
Asset Writedown	77.71	-124.06	-2,185	-287.05	459.73	-229.58	Upgrade
Other Unusual Items	-69.86	-	-	-	-31.71	-	Upgrade
Pretax Income	511.47	312.58	-1,791	170.82	852.46	145.01	Upgrade
Income Tax Expense	1.7	2.07	1.99	3.38	1.85	-9.57	Upgrade
Earnings From Continuing Operations	509.77	310.5	-1,793	167.44	850.62	154.58	Upgrade
Net Income to Company	509.77	310.5	-1,793	167.44	850.62	154.58	Upgrade
Minority Interest in Earnings	-0.5	-0.74	5.91	2.15	-1.32	0.49	Upgrade
Net Income	509.28	309.76	-1,787	169.58	849.29	155.07	Upgrade
Net Income to Common	509.28	309.76	-1,787	169.58	849.29	155.07	Upgrade
Net Income Growth	-	-	-	-80.03%	447.68%	-89.77%	Upgrade
Basic Shares Outstanding	74	74	74	74	74	74	Upgrade
Diluted Shares Outstanding	74	74	74	74	74	74	Upgrade
Shares Change (YoY)	0.47%	0.46%	-0.12%	0.14%	0.18%	-0.20%	Upgrade
EPS (Basic)	6.88	4.19	-24.20	2.30	11.53	2.11	Upgrade
EPS (Diluted)	6.86	4.18	-24.20	2.29	11.50	2.10	Upgrade
EPS Growth	-	-	-	-80.09%	447.62%	-89.77%	Upgrade
Dividend Per Share	5.450	5.450	5.300	5.300	5.300	5.300	Upgrade
Dividend Growth	2.83%	2.83%	-	-	-	-	Upgrade
Operating Margin	74.72%	65.21%	62.41%	64.86%	63.31%	62.43%	Upgrade
Profit Margin	58.85%	36.69%	-222.73%	22.80%	114.31%	19.61%	Upgrade
EBITDA	658.14	562.35	512.05	492.44	481.5	503.25	Upgrade
EBITDA Margin	76.05%	66.60%	63.81%	66.19%	64.81%	63.65%	Upgrade
D&A For Ebitda	11.53	11.7	11.28	9.88	11.11	9.66	Upgrade
EBIT	646.61	550.65	500.77	482.56	470.38	493.59	Upgrade
EBIT Margin	74.72%	65.21%	62.41%	64.86%	63.31%	62.43%	Upgrade
Effective Tax Rate	0.33%	0.66%	-	1.98%	0.22%	-	Upgrade

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.